Year: 2019

Declaration of number of voting rightsInformation relating to the total number of voting rights and shares as required by L.233-8 II of the code of commerce and article 223-16 of the general rulesof the French market authority (AMF).AttachmentCP Droitsdevote_13nov19_VA

                      Déclaration du nombre de droits de voteInformations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du code du commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers.Pièce jointeCP Droitsdevote_13nov19_VF

NEW YORK, Nov. 19, 2019 (GLOBE NEWSWIRE) — Exxe Group, Inc. (OTC PINK: AXXA), a diversified company focused on synergistic acquisitions in real estate, sustainable technology, media, financial services and agribusiness, announced today strong year-over-year and quarterly financial results for the period ended September 30, 2019.Operating SnapshotRevenue grew by a substantial 484% to $2,610,756 as compared with $448,021 for the same period last year. On a quarter-to-quarter basis, top-line rose by an impressive 117%, as compared with the June 2019 period. Operating income jumped by 31% to $245,921 versus $187,141 in the corresponding quarter in 2019. Net loss for the quarter was ($270,713), reflecting financing costs related to the series of acquisitions executed during the period. For the first six months of the fiscal year, Exxe...

Company continues to expand growth and operations throughout the USPHOENIX, Nov. 19, 2019 (GLOBE NEWSWIRE) — Direct Solar a subsidiary of SinglePoint Inc. (OTCQB: SING), a leading residential and commercial solar brokerage, continues to exceed revenue growth targets and has been pivotal to improving the Company’s financials. Quarter Three 2019 Highlights of Direct Solar include:Contracts Originated $4,965,975 (installs set for Q4 and Q1 2020)Opened in three new statesLaunched high school partnership program with 47 Texas based high schoolsSigned MOU with SchollyMe to develop online and mobile solar purchasing abilityLaunched Direct Solar Capital and Direct Solar Commercial“We have been on an upswing as more people are finding out about Direct Solar and what we bring to the market. From homeowners to developers and commercial building...

Q3 Revenue Increased 22% Year-Over-YearGross Margin Improved to 75.3% Due to Better Revenue MixNEW YORK, Nov. 19, 2019 (GLOBE NEWSWIRE) — Alternus Energy Inc. (OTC: ALTN), a global renewable energy company, today announced its financial results for the third quarter ended September 30, 2019.Key Financial Highlights for Q3 2019:Revenues increased by 22% to $0.993 millionGross profit increased by 71% to $0.748 millionGross margin improved to 75%, up from 54%Adjusted EBITDA (a non-GAAP measurement) declined to a loss of $0.132 million from a positive $0.212 million in 2018Key Business Highlights for Q3 2019:Filed a SEC Form 10 on August 13 to become a SEC reporting companyFiled first SEC Form 10-Q with SEC for three and nine months ended September 30, 2019“We are very pleased with our strong third quarter results year-over-year, led...

GRAND RAPIDS, Mich., Nov. 19, 2019 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2019 fourth quarter and full year financial results on Thursday, Jan. 23, 2020, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website.Brad Kessel, President and CEO, Rob Shuster, retiring CFO, and Steve Erickson, incoming CFO will review the quarterly and full year results in a conference call for investors and analysts beginning at 11:00 am ET on Thursday, Jan. 23, 2020.To participate in the live conference call, please dial 1-866-200-8394. Also the conference call will be accessible through an...

Oslo, 19 November 2019: Scatec Solar has signed an agreement with FMO, the Dutch development bank, for FMO to take a 40% equity stake in Scatec Solar’s 55 MW Chigirin project in Ukraine. The total investment for the project is estimated at EUR 54 million and is funded by non-recourse debt financing from the European Bank for Reconstruction and Development (EBRD), The Nordic Environment Finance Corporation (NEFCO) and Swedfund. FMO’s equity stake is financed by the Access to Energy Fund, which FMO manages on behalf of the Dutch government.“We are pleased to announce this second equity co-investment with our long-term partner FMO. We are working with FMO as a debt and equity partner on a range of projects in Ukraine and internationally and we expect more cooperation in the years to come”, says Raymond Carlsen CEO of Scatec Solar.“After...

 19 November 2019 – 17:15 CETArcelorMittal announces the issuance of €750,000,000 1.000 per cent. notes due 19 May 2023 (the “2023 Notes”) and €750,000,000 1.750 per cent. notes due 19 November 2025 (the “2025 Notes” and together with the 2023 Notes, the “Notes”).The issuance closed today. The Notes were issued under ArcelorMittal’s €10,000,000,000 wholesale Euro Medium Term Notes Programme.The proceeds of the issuance will be used for general corporate purposes including refinancing of existing indebtedness.Important note: This press release does not, and shall not, in any circumstances constitute a public offering by ArcelorMittal of the Notes nor an invitation to the public in connection with any offer. No communication and no information in respect of the issuance of the Notes may be distributed to the public in any jurisdiction where...

Company AnnouncementDARZALEX® approved in Europe in combination with lenalidomide and dexamethasone as treatment for adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantApproval follows positive opinion by European Committee for Medicinal Products for Human Use (CHMP) in OctoberApproval based on data from Phase III MAIA studyCopenhagen, Denmark; November 19, 2019 – Genmab A/S (Nasdaq: GMAB) announced today that the European Commission (EC) has granted marketing authorization for DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (Rd) as treatment for adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT). The EC approval follows a positive opinion issued for DARZALEX by the CHMP of the European Medicines...

ALISO VIEJO, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — Laguna Treatment Hospital, an American Addiction Centers facility and leading provider of substance use treatment, has welcomed Laura Giffin as the facility’s Alumni Services Manager. In her new role, Giffin plans to further incorporate Laguna Treatment Hospital into the community she calls home.Addiction is an illness very personal to Giffin. Growing up, she witnessed the actions, consequences and untimely deaths of loved ones due to the disease. After her first drink at age 12, she learned that addiction also affected her. After a number of years of not addressing her issues with alcohol, a tumultuous relationship and a brief relapse, Giffin ultimately sought and maintained her sobriety for her two sons.Almost immediately after beginning life in recovery, she battled a number...